Abstracts Archive - Page 1613 of 2425 - ACR Meeting Abstracts

Abstract Number: 2940 • 2016 ACR/ARHP Annual Meeting
Bechet’s Disease and Sleep Quality in Korean Patients
Chang-Nam Son¹, Ji Min Lee¹, Hye-Jin Jeong², Ji-Min Kim¹, Sang-Hyon Kim¹, Sung Soo Kim³ and Seung-Hyeon Bae⁴, ¹Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea, The Republic of, ²Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea, ³Division of Rheumatology, Department of Internal Medicine, Ulsan University School of Medicine, GangNeung Asan Hospital, Gangneung, South Korea, ⁴Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
Background/Purpose: The purpose of this study was to find out the effects of sleep quality on Behcet’s disease in Korean population. We also investigated the…
Abstract Number: 2941 • 2016 ACR/ARHP Annual Meeting
Optimization of Adalimumab on Refractory Uveitis of Behcet’s Syndrome. Multicenter Study of 23 Patients
Carlos Fernández-Díaz¹, Ricardo Blanco¹, Vanesa Calvo-Río¹, Javier Loricera¹, J. Sanchez-bursón², Norberto Ortego Centeno³, Jose L. García Serrano⁴, Miguel Cordero⁵, J. Vazquez⁶, Emma Beltran⁷, Elia Valls⁸, O. Maiz Alonso⁹, Ana Blanco¹⁰, Ignacio Torre¹¹, Angel García-Aparicio¹², F.j Toyos-saénz¹³, L. Martinez-Costa¹⁴, Lucia C. Domínguez-Casas¹, Natalia Palmou¹ and Miguel Angel Gonzalez-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ²Rheumatology, Hospital Valme, Hospital Valme, Sevilla, Spain, ³Medicine Department, Hospital Universitario San Cecilio, Granada, Spain, ⁴Ophthalmology, Hospital Universitario San Cecilio, Granada, Spain, ⁵Ophthalmology, Hospital de León, León, Spain, ⁶Rheumatology, Hospital de Ferrol, Ferrol, Spain, ⁷Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain, ⁸Rheumatology, Hospital Dr. Peset., Valencia, Spain, ⁹Rheumatology, Hospital Donostia, San Sebastian, Spain, ¹⁰Ophthalmology Department. Donostia University Hospital, Donostia, Spain, ¹¹Rheumatology, Hospital de Basurto, Bilbao, Spain, ¹²Rheumatology, Ophthalmology and rheumatology, Hospital de Ferrol, Ferrol, Ferrol, Spain, ¹³Rheumatology,, Hospital Virgen de la Macarena, Sevilla, Spain, ¹⁴Hospital Dr. Peset., Valencia, Spain
Background/Purpose: In non-infectious no anterior uveitis, adalimumab (ADA) is the only biologic drug that has shown efficacy in phase III randomized, double blind studies,…
Abstract Number: 2942 • 2016 ACR/ARHP Annual Meeting
Sequencing of 16S rRNA Reveals a Distinct Salivary Microbiome Signature in Behcet’s Disease
Patrick Coit¹, Gonca Mumcu², Filiz Ture Ozdemir³, Ali Ugur Unal⁴, Ugur Alpar⁵, Nagihan Bostanci⁶, Tulin Ergun⁷, Haner Direskeneli⁴ and Amr Sawalha¹, ¹Division of Rheumatology, University of Michigan, Ann Arbor, MI, ²Department of Health Management, Marmara University, Faculty of Health Sciences, Istanbul, Turkey, ³Marmara University, School of Medicine, Department of Immunology, Istanbul, Turkey, ⁴Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, ⁵Faculty of Dentistry, Marmara University, Istanbul, Turkey, ⁶Division of Periodontology, Department of Dental Medicine, Karolinska Institute, Stockholm, Sweden, ⁷Department of Dermatology, Faculty of Medicine, Marmara University, Istanbul, Turkey
Background/Purpose: Results: This is the first high-throughput sequencing-based evaluation of the salivary microbiome in BD. Salivary microbiome of BD patients has a specific signature…
Abstract Number: 2943 • 2016 ACR/ARHP Annual Meeting
Relationship Between Menstruation and Symptoms of Behcet’s Syndrome
Gul Guzelant¹, Yesim Ozguler², Sinem Nihal Esatoglu³, Guzin Karatemiz², Huri Ozdogan², Sebahattin Yurdakul¹, Hasan Yazici¹ and Emire Seyahi¹, ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Division of Rheumatology, Istanbul, Turkey, ³Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
Background/Purpose: It is well known that menstruation triggers several conditions such as migraine, recurrent aphtous stomatitis and acne vulgaris in otherwise healthy individuals (1). It…
Abstract Number: 2944 • 2016 ACR/ARHP Annual Meeting
Use of Muscle Biopsies for the Diagnosis of Systemic Vasculitis in a Rheumatology Service
Samantha Rodriguez-Muguruza^1,2, Juana Sanint³, Xavier Saenz-Sarda⁴, Agueda Prior², Yaiza Garcia⁵, Maria Lourdes Mateo⁶, Susana Holgado⁶, Jeronima Cañellas², Melania Martínez-Morillo⁷, Xavier Tena⁶ and Alejandro Olivé¹, ¹Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, ²Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, ³Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ⁴Anathomy Pathology, Germans Trias i Pujol Hospital, Barcelona, Spain, ⁵Rheumatology, Germans Trias i Pujol Hospital, Barcelona, Spain, ⁶Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, ⁷Rheumatology, Germans Trias i Pujol University Hospital, Barcelona, Spain
Background/Purpose: Systemic vasculitis comprises a group of diseases characterized by non-infectious inflammation of vessels in various organs. Histopathological confirmation of systemic vasculitis is required for…
Abstract Number: 2945 • 2016 ACR/ARHP Annual Meeting
Systematic Review: “Efficacy and Safety of Biological Versus Immunosuppressive Therapy Compared to Placebo in the Treatment of Uveitis Associated with BehçEt’s Disease.”
Ana Urruticoechea-Arana¹, Tatiana Cobo-Ibáñez², Virginia Villaverde García³, Montserrat Santos-Gómez⁴, Kelly Vargas Osorio⁵, Federico Díaz-González⁶, Leslie Fariñas Padrón⁵, Vanesa Calvo-Río⁷ and Ricardo Blanco Alonso⁷, ¹Hospital Can Misses, Ibiza, Spain, ²Hospital Universitario Reina Sofía, Universidad Europea de Madrid, Madrid, Spain, ³Rheumatology, Hospital Universitario de Móstoles, Móstoles, Spain, ⁴Rheumatology, Hospital Can Misses, Ibiza, Spain, ⁵Family and Community Medicine, Hospital Can Misses, Ibiza, Spain, ⁶Rheumatology, Hospital Universitario de Canarias, S/C Tenerife, Spain, ⁷Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain
Background/Purpose:
Abstract Number: 2946 • 2016 ACR/ARHP Annual Meeting
Large Scale Genetic Analysis in BehçEt Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci
Lourdes Ortiz Fernández¹, Francisco David Carmona², Marco Antonio Montes Cano³, José Raúl García Lozano³, Marta Conde Jaldón⁴, Norberto Ortego Centeno⁵, María Jesús Castillo Palma⁶, Gerard Espinosa⁷, Genaro Graña Gil⁸, Juan Sánchez Bursón Sr.⁹, María Rosa Juliá¹⁰, Roser Solans¹¹, Ricardo Blanco Alonso¹², Ana Celia Barnosi Marín¹³, Ricardo Gómez de la Torre¹⁴, Patricia Fanlo Mateo¹⁵, Mónica Rodriguez Carballeira¹⁶, Luis Rodriguez-Rodriguez¹⁷, Teresa Camps¹⁸, Santos Castañeda¹⁹, Juanjo J Alegre Sancho²⁰, Javier Martín² and María Francisca Gonzalez Escribano²¹, ¹Instituto de Parasitología y Biomedicina "López-Neyra", CSIC, Granada, Spain, ²Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, ³Departament of Immunology, Hospital Universitario Virgen del Rocío (IBiS,CSIC,US), Sevilla, Spain, ⁴Immunology, Hospital Universitario Virgen del Rocío, Sevilla, Spain, ⁵Systemic Autoimmune Diseases Unit, Hospital Universitario San Cecilio, Granada, Spain, ⁶Department of Internal Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain, ⁷Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, ⁸Rheumatology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruna, Spain, ⁹Rheumatology, Hospital de Valme., Sevilla, Spain, ¹⁰8Department of Immunology, Hospital Universitari Son Espases, Palma de Mallorca, Spain, ¹¹Autoimmune Systemic Diseases Unit, Department of Internal Medicine, Hospital Vall d'Hebron, Autonomous University of Barcelona, Spain, Barcelona, Spain, ¹²Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ¹³Department of Internal Medicine, Complejo Hospitalario Torrecárdenas, Almeria, Spain, ¹⁴Departament of Internal Medicine, Hospital Universitario Central de Asturias, Asturias, Spain, ¹⁵Department of Internal Medicine, Hospital Virgen del Camino, Pamplona, Spain, ¹⁶Departament of Internal Medicine, Hospital Universitari Mútua Terrassa, Terrasa, Spain, ¹⁷Rheumatology Service, Hospital Clínico San Carlos, Madrid, Spain, ¹⁸Departament of Internal Medicine, Hospital Regional Universitario de Málaga, Málaga, Spain, ¹⁹Rheumatology, Hospital de la Princesa, IIS-IP, Madrid, Spain, ²⁰Department of Rheumatology, Hospital Universitario Doctor Peset, Valencia, Spain, ²¹Hospital Universitario Virgen del Rocío (IBiS,CSIC,US), Sevilla, Spain
Background/Purpose: Behçet’s disease (BD) is a complex immune-mediated vasculitis which aetiology remains unknown although some evidences suggest that certain infectious agents and environmental factors may…
Abstract Number: 2947 • 2016 ACR/ARHP Annual Meeting
Adalimumab Versus Infliximab in Cystoid Macular Edema of Uveitis Associated to BehçEt Disease. Multicenter Study of 34 Patients
Lucia Cristina Domínguez-Casas¹, Vanesa Calvo-Río¹, Ricardo Blanco², Carlos Fernández-Díaz¹, Paz Rodríguez-Cundín³, Emma Beltran⁴, Marisa Hernández-Garfella⁵, Jose M Herreras⁶, Miguel Cordero-Coma⁷, Marina Mesquida⁸, Alfredo Adan⁹, M. Victoria Hernández¹⁰, David Diaz-Valle¹¹, Ignacio Torre-Salaberri¹², Manuel Díaz-Llopis¹³, Roberto Gallego¹⁴, Olga Maiz-Alonso¹⁵, Santos Insua¹⁶, Félix Francisco¹⁷, Raquel Almodóvar González¹⁸, Oscar Ruiz Moreno¹⁹, Fernando Jiménez-Zorzo²⁰, Javier Manero²¹, Myriam Gandía²², Joan Miquel Nolla²³, Nuria Vegas-Revenga²⁴, Natalia Palmou-Fontana¹ and Miguel Angel Gonzalez-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ²Rheumatology Department. Hospital Universitario Marqués de Valdecilla, Santander, Spain, ³Preventive Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ⁴Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain, ⁵Ophtamology, Hospital General Universitario de Valencia, Valencia, Spain, ⁶Ophthalmology, Hospital Universitario, IOBA, Valladolid, Spain, ⁷Ophthalmology, Hospital de León, León, Spain, ⁸Ophthalmology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁹Ophthalmology, Hospital Clinic de Barcelona,, Barcelona, Spain, ¹⁰Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ¹¹Ophthalmology Department, Hospital Clínico San Carlos, Madrid, Spain, ¹²Rheumatology, Hospital de Basurto, Bilbao, Spain, ¹³Hospital Universitario La Fe, Valencia, Spain, ¹⁴Ophtalmology, Hospital Universitario La Fe, Valencia, Spain, ¹⁵Hospital Universitario Donostia, Donostia, Spain, ¹⁶Rheumatology, Hospital Universitario Santiago de Compostela, La Coruña, Spain, ¹⁷Rheumatology, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Spain, ¹⁸Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, ¹⁹Ophthalmology and Rheumatology., Hospital Miguel Servet, Zaragoza, Spain, ²⁰Hospital Miguel Servet, Zaragoza, Spain, ²¹Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, ²²Rheumatology, Hospital Puerta del Mar, Cadiz, Spain, ²³Rheumatology, Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ²⁴Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain
Background/Purpose: Cystoid macular edema (CME) is the most serious complication of uveitis and the most common cause of blindness in uveitis. Our aim was…
Abstract Number: 2948 • 2016 ACR/ARHP Annual Meeting
Fecal Calprotectin Level Is Useful in Identifying Active Disease in Behçet’s Syndrome Patients with Gastrointestinal Involvement: A Controlled Study
Sinem Nihal Esatoglu¹, Ibrahim Hatemi², Yesim Ozguler³, Gulen Hatemi³, Hafize Uzun⁴, Aykut Ferhat Celik⁵ and Hasan Yazici³, ¹Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University, Cerrahpasa Medical School, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey, ³Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ⁴Biochemistry, Istanbul University, Cerrahpasa Medical School, Department of Biochemistry, Istanbul, Turkey, ⁵Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey
Background/Purpose: The fecal calprotectin (FC) is widely used as a non-invasive method for identifying patients with active Crohn’s disease (CD) and ulcerative colitis. Gastrointestinal involvement…
Abstract Number: 2949 • 2016 ACR/ARHP Annual Meeting
Surgical Method for Aortic Root Involvement of Behcet Disease
Byeongzu Ghang¹, Suk Jung Choo², Oh Chan Kwon³, Seokchan Hong⁴, Yong-Gil Kim⁵, Chang-Keun Lee⁵ and Bin Yoo⁵, ¹Division of Rheumatology, Department of Internal Medicine, Univerisy of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ²Division of Thoracic and Cardiovascular Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, The Republic of, ³Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, The Republic of, ⁴Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ⁵Division of Rheumatology, Department of Internal Medicine, Department of Rheumatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
Background/Purpose: Aortic regurgitation (AR) in Behcet disease is a rare but very fatal condition. Many patients require a second or third operation after simple aortic…
Abstract Number: 2950 • 2016 ACR/ARHP Annual Meeting
Cogan Syndrome: Treatment and Outcome from French Nationwide Retrospective Study and Literature Review of 62 Patients
CHARLOTTE DURTETTE¹, Mathieu Resche Regon², eric hachulla³, anne Graslands⁴, Thomas Papo^5,6, Jacques Pouchot⁷, jean Emmanuel kahn⁸, Thierry Zenone⁹, cedric landron¹⁰, benoit de Wazieres¹¹, Robin Dhote¹², Christophe Deligny¹³, Guillaume Gondran¹⁴, Edouard Pertuiset¹⁵, thomas quemeneur¹⁶, Bertrand Lioger¹⁷, Pascal Sève¹⁸, Christian Lavigne¹⁹, thomas le Galllou²⁰, Mohamed Hamidou²¹, claire delaunay²², Olivier Fain²³ and Arsene Mekinian²⁴, ¹SAINT ANTOINE HOSPITAL, PARIS, France, ²biostatistics Saint Louis Hospital, paris, France, ³chru lille hospital, lille, France, ⁴Service de Médecine interne, Hôpital Louis-Mourier, colombes, France, ⁵Department of Internal Medicine, AP-HP Bichat Hospital, Paris, France, ⁶Internal Medicine, Hôpital Bichat, Université Paris-Diderot, Paris, France, ⁷Paris University, Internal medicine, Paris, France, ⁸foch hospital, foch, France, ⁹Internal Medicine, Valence Hospital, Valence, France, ¹⁰service de médecine interne, CH Poitiers, CHU Poitiers, poitiers, France, ¹¹CHU de Nîmes, nimes, France, ¹²Internal Medicine, Hospital Avicenne, Bobigny, France, ¹³Zobda Quitman Hospital, Rheumatology and Internal Medicine, Fort de France, Martinique, ¹⁴Internal Medicine Department, Limoges, France, ¹⁵CH René Dubos, Pontoise, France, ¹⁶valenciennes hospital, valenciennes, France, ¹⁷INTERNAL MEDICINE, tours, France, ¹⁸Internal medicine, Internal medicine department, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France, ¹⁹CHU Angers, department of Internal Medicine, Angers, France, ²⁰rennes CHU hospital, rennes, France, ²¹Internal Medicine Department, Internal Medicine Department, Nantes University Hospital, Nantes, France, ²²Centre hospitalier niort, niort, France, ²³Service de médecine interne. Hôpital Saint-Antoine., Paris, France, ²⁴DHU2iB, Internal Medicine Saint Antoine Hospital, PARIS, France
Background/Purpose: Methods: Sixty two patients were included with median age 37 [2-76] and 31/62 (50%) women. At the diagnosis, 61 (98%) had audiovestibular involvement,…
Abstract Number: 2951 • 2016 ACR/ARHP Annual Meeting
Patient Outcomes in Primary Angiitis of the Central Nervous System
Elisabeth Ray¹, Didem Saygin², Anabelle Morales-Mena³, William Messner⁴, Leonard H. Calabrese⁵ and Rula A Hajj-Ali⁶, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic, Cleveland, OH, ³Rheumatology, Hillcrest Hospital, Mayfield Heights, OH, ⁴Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁵Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ⁶Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Results: 1855 patient records were identified using the ICD-9 code for cerebral angiitis. 78 patients met inclusion criteria, of which 27 responded to the questionnaires…
Abstract Number: 2952 • 2016 ACR/ARHP Annual Meeting
Differentiation Between Neurosarcoidosis and Primary CNS Vasculitis Based on Clinical and Cerebrospinal Fluid Parameters
Didem Saygin¹, Leonard H. Calabrese², Elisabeth Ray¹, William Messner³, Jinny Tavee⁴ and Rula A Hajj-Ali⁵, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Neuromuscular diseases, Cleveland Clinic, Cleveland, OH, ⁵Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Background/Purpose: Neurosarcoidosis is one of the great mimickers of primary angiitis of central nervous system (PACNS) in terms of disease presentation, imaging and pathologic findings.…
Abstract Number: 2953 • 2016 ACR/ARHP Annual Meeting
Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
Elisabeth Ray¹, Didem Saygin¹, Seby John², William Messner³, Ken Uchino⁴, Leonard H. Calabrese⁵ and Rula A Hajj-Ali⁶, ¹Rheumatology, Cleveland Clinic, Cleveland, OH, ²Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Cerebrovascular Center, Cleveland Clinic Foundation, Cleveland, OH, ⁵Rheumatic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ⁶Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Background/Purpose: Reversible Cerebral Vasoconstriction Syndrome (RCVS) is an important mimic of Primary Angiitis of the Central Nervous System (PACNS). Distinct clinical and diagnostic features differentiate…
Abstract Number: 2954 • 2016 ACR/ARHP Annual Meeting
Anti-IL6-R Tocilizumab in Refractory Uveitis Associated with BehçEt’s Disease. Multicenter Study of 11 Patients
Lucia C. Domínguez-Casas¹, Vanesa Calvo-Río¹, Ricardo Blanco¹, Emma Beltran², L. Martinez-Costa³, Elia Valls-Pascual⁴, Marisa Hernández-Garfella⁵, Antonio Atanes⁶, Miguel Cordero-Coma⁷, Joan Miquel Nolla⁸, Carmen Carrasco-Cubero⁹, Javier Loricera¹, MC Gonzalez-Vela¹⁰, Nuria Vegas-Revenga¹¹, Carlos Fernández-Díaz¹, Natalia Palmou-Fontana¹ and Miguel Angel Gonzalez-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ²Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain, ³Hospital Dr. Peset., Valencia, Spain, ⁴Rheumatology, Hospital Dr. Peset., Valencia, Spain, ⁵Ophtamology, Hospital General Universitario de Valencia, Valencia, Spain, ⁶Rheumatology Division, INIBIC-Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruna, Spain, ⁷Ophthalmology, Hospital de León, León, Spain, ⁸Rheumatology, Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ⁹Rheumatology, Complejo Universitario de Badajoz, Badajoz, Spain, ¹⁰Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, ¹¹Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain
Background/Purpose: Treatment recommended in severe and/or refractory uveitis of Behçet disease is anti-TNFα therapy, usually infliximab (IFX) or adalimumab (ADA) (Levy-Clarke et al Ophthalmology…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].